Siebert, R.

patient lymphoma treatment expression transcript hrs cells sample mantle cell lymphoma csf 1r hrs cell lines analysis induction blood control hodgkin trial region response cbfa 2t expression cbfa 2t figure number level promoter mrd status activation remission experiment result mantle mrd assessment study assessment element prognostic status survival immunochemotherapy cell transplantation non-hodgkin genomic activity hl -60 cells european maintenance month transcription disease rituximab erasmus mc cell lines high-dose factor leukemia j clin oncol nature l 540cy cells 19 q 12 csf 1r ltr 2 years cycle outcome article canonical impact diagnosis noncanonical university gapdh volume csf 1r transcripts fl ow cytometry / european journal primer signi probe position 540cy product firmed